Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3137894
Reference Type
Journal Article
Title
Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms
Author(s)
Jiménez-Candil, J; Hernández, J; Martín, A; Moríñigo, J; Perdiguero, P; Bravo, L; Ruiz, S; Sánchez, PL
Year
2015
Is Peer Reviewed?
Yes
Journal
Journal of Interventional Cardiac Electrophysiology
ISSN:
1383-875X
EISSN:
1572-8595
Volume
44
Issue
2
Page Numbers
187-195
Language
English
PMID
26306456
DOI
10.1007/s10840-015-0050-0
Web of Science Id
WOS:000361980900012
Abstract
PURPOSE:
To determine whether monomorphic ventricular tachycardias (VTs) have different characteristics and/or responses to antitachycardia pacing (ATP) with respect to the indication-primary prevention (PP) versus secondary prevention (SP)-among ICD patients with left ventricular dysfunction.
METHODS:
We prospectively studied 551 VT (cycle length [CL] 329 ± 35 ms; PP 34%) occurring in 67 ICD patients with left ventricular dysfunction (LVEF 35 ± 8%). ICD programming was standardized, including ATP for slow (CL 400-321 ms) and fast VT (CL 250-320 ms). We analyzed the following aspects: CL, percentage of variability of the 12 RR intervals prior to ATP (P-RR)-which was calculated by dividing the mean difference between each R-R interval with the next one by the CL × 100-and type of termination: immediate (VT ceased immediately upon ATP completion) or delayed (VT persisted after ATP).
RESULTS:
ATP was successful in 86% of VTs. VTs occurring in SP patients had a lower P-RR, median (IQR) 2.7% (1.2-3.7) versus 1.9% (0.9-3.2); p = 0.002; they terminated immediately after ATP less frequently (27% versus 12%; p < 0.001), and although they were more frequently slow (51% versus 67%; p = 0.01), ATP was less effective in them, 92 versus 80% (p = 0.02).
CONCLUSIONS:
VTs occurring in SP patients are slower, more stable, and they terminate less frequently at ATP. Therefore, compared with PP, SP patients seem to have fewer self-terminating VTs.
Keywords
Implantable cardiac defibrillator; Ventricular tachycardia; Antitachycardia pacing; Shock
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity